| Donald E Kirton, | |
|
135 Dowling Way Department Of Ob/gyn, Farmington, CT 06030-0001 | |
| (860) 679-2792 | |
| Not Available |
| Full Name | Donald E Kirton |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 135 Dowling Way Department Of Ob/gyn, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538368873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 246927 (Massachusetts) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 75523 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baystate Medical Practices Inc | 5991602971 | 1015 |
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
During the past decade, babies born to women with type 2 diabetes have shown an increasing number of serious health problems - including stillbirth and birth defects, such as brain, spine and heart congenital malformations that can lead to infant deaths, according to a study published in the February issue of Diabetes Care.
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
Politics swirled around events designed to mark the sixth anniversary of the state's health reforms - with a focus on GOP presidential hopeful Mitt Romney, who signed the measure when he was governor and is now campaigning against the federal health law, which includes many similar provisions.
› Verified 3 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
During the past decade, babies born to women with type 2 diabetes have shown an increasing number of serious health problems - including stillbirth and birth defects, such as brain, spine and heart congenital malformations that can lead to infant deaths, according to a study published in the February issue of Diabetes Care.
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
Politics swirled around events designed to mark the sixth anniversary of the state's health reforms - with a focus on GOP presidential hopeful Mitt Romney, who signed the measure when he was governor and is now campaigning against the federal health law, which includes many similar provisions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald E Kirton, 135 Dowling Way Department Of Ob/gyn, Farmington, CT 06030-0001 Ph: (860) 679-2792 | Donald E Kirton, 135 Dowling Way Department Of Ob/gyn, Farmington, CT 06030-0001 Ph: (860) 679-2792 |
News Archive
During the past decade, babies born to women with type 2 diabetes have shown an increasing number of serious health problems - including stillbirth and birth defects, such as brain, spine and heart congenital malformations that can lead to infant deaths, according to a study published in the February issue of Diabetes Care.
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.
Today at the World Health Congress, Cisco (NASDAQ: CSCO) unveiled findings from a global health leader survey on national health sector innovation. The most significant findings from the online survey, commissioned by the Cisco® Internet Business Solutions Group (IBSG) and conducted by Princeton Survey Research Associates International (PSRAI), reveal that collaboration and information-sharing among health professionals have the greatest near-term potential for facilitating large-scale health sector innovation.
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma, a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association meeting being held June 10-13, 2010 in Barcelona, Spain.
Politics swirled around events designed to mark the sixth anniversary of the state's health reforms - with a focus on GOP presidential hopeful Mitt Romney, who signed the measure when he was governor and is now campaigning against the federal health law, which includes many similar provisions.
› Verified 3 days ago
Richard Kent Wagner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-3387 Fax: 860-679-1494 | |
Dr. Claudio A. Benadiva, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 860-679-4580 | |
Molly Brewer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Uconn Medical Group/neag Cancer Center, Farmington, CT 06030 Phone: 860-679-2100 Fax: 860-679-4815 | |
Reeva Makhijani, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 844-467-3483 | |
Donald B Maier, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2 Batterson Park Rd, Farmington, CT 06032 Phone: 860-678-3428 | |
Nicole Gavin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2329 Fax: 860-679-1494 | |
Dr. Chito Umenyi Nwana, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2853 |